Monthly Archives: November 2017

ContraVir collaborate to develop and commercialize antiviral medication candidate CMX157 Chimerix.

We start to see the licensing of CMX157 as a substantial first step toward creating a leading pipeline of targeted antiviral treatments. Along with FV-100, our drug applicant for the treatment of shingles, we are proud our pipeline consists of two Stage 2 assets now.’.. Chimerix, ContraVir collaborate to develop and commercialize antiviral medication candidate CMX157 Chimerix, Inc. a biopharmaceutical organization developing novel, oral antivirals in areas of high unmet medical need, and ContraVir Pharmaceuticals, Inc. , a biopharmaceutical company focused on the development and commercialization of targeted antiviral therapies, announced today that the firms have entered into a strategic collaboration for the additional clinical development and commercialization of CMX157. Continue reading

Can Particular K help treat depression?

Can ‘Particular K’ help treat depression? What’s the latest recreational drug to create its way to the medical field? Ketamine, also known as ‘Special K enhancing processes .’ The club drug, typically utilized by veterinarians as a cat tranquilizer, is said to provide individuals an ‘instant’ relief from depressive disorder, according to a fresh study. Doctors at Ben Taub General Medical center in Houston are now experimentally using the drug to treat some patients who arrive to the emergency room with suicidal major depression, NPR reported. Is there an antidepressant shortage we have no idea about? Dr. Continue reading

Bayer has finished the acquisition of completely of the shares of Dihon Pharmaceutical Group Co.

These elements include those talked about in Bayer’s open public reports which can be found on the Bayer site at The business assumes no liability whatsoever to revise these forward-searching statements or even to conform them to upcoming events or developments.. Leverkusen, 3 November, 2014– Bayer has finished the acquisition of completely of the shares of Dihon Pharmaceutical Group Co., Ltd., Kunming, Yunnan, China, a privately kept pharmaceutical company specializing mainly in over-the-counter dermatology products and natural traditional Chinese medication products for several women’s wellness indications. Bayer paid a price of CNY 3.6 billion . This acquisition is normally further proof our try to strengthen our Existence Sciences portfolio with strategic bolt-on acquisitions, stated Dr. Continue reading

And theyve developed an artificial sleeve that spurs fast curing whenever a car wreck.

Knothe, who spent some time working with patients suffering bone bone or cancer tumor loss from traumatic accidental injuries, knows that sometimes there isn’t enough periosteum to create a sleeve. With support from the Case-Coulter Translational Research Program, the few designed an artificial periosteum and Knothe Tate created the novel implant, a sleeve made of components approved by the Food & Drug Administration for various other treatments. In sheep tests, collagen, collagen and cells scraped from periosteum, and bits of periosteum were tucked into the artificial sleeves. Sheep treated with bits of periosteum healed fastest, followed by people that have collagen and cells. Continue reading

As a CDA member company.

Their efforts advantage workers and their families, agents and brokers, along with the entire disability insurance sector.’ While disabling illness is a growing problem, many workers are unaware of their risk. The CDA gives tools on their website, to help employees assess their threat of disability and become prepared for the possible outcomes.0 million Cardiovascular Systems, Inc.0 million Revenue from reorders grew to 93 % of total revenue from 89 % Gross margin rose to 77 % from 73 % Adjusted EBITDA loss improved 58 % to $ million Net loss improved 22 % to $ , a medical device business developing and commercializing innovative interventional treatment systems for vascular disease, today reported financial outcomes because of its fiscal fourth one fourth and year ended June 30, 2010. Continue reading